DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
L 756423
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
L 756423
×
Maximum Phase:
2
First Approval:
None
UNII:
862SGU1BRL
Molecule Type:
Small molecule
Molecular Formula:
C39H48N4O5
Molecular Weight:
652.84
AlogP:
4.22
PSA:
118.28
HBD:
4.0
HBA:
#RotB:
11.0
Source:
O-(2-FLUOROETHYL)-L-TYROSINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
O-(2-FLUOROETHYL)-L-TYROSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P6VBV68WPV
Molecule Type:
Small molecule
Molecular Formula:
C11H14FNO3
Molecular Weight:
227.24
AlogP:
0.99
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LTX-109
2
Small molecule
Investigational
Unknown
Unknown
Hidradenitis Suppurativa; Impetigo; Severe Acute Respiratory Syndrome; Staphylococcal Infections
Cell membrane disrupting agent
LTX-109
×
Maximum Phase:
2
First Approval:
None
UNII:
HO813QDF65
Molecule Type:
Small molecule
Molecular Formula:
C43H69N11O3
Molecular Weight:
788.1
AlogP:
3.79
PSA:
252.91
HBD:
11.0
HBA:
#RotB:
18.0
Source:
AT-7519
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Multiple Myeloma; Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell
Cyclin-dependent kinase inhibitor
AT-7519
×
Maximum Phase:
2
First Approval:
None
UNII:
X1BF92PW9T
Molecule Type:
Small molecule
Molecular Formula:
C16H17Cl2N5O2
Molecular Weight:
382.25
AlogP:
2.45
PSA:
98.91
HBD:
4.0
HBA:
#RotB:
4.0
Source:
BISOCTRIZOLE
2
Small molecule
Investigational
Unknown
Unknown
Urticaria
Sunscreen
BISOCTRIZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8NT850T0YS
Molecule Type:
Small molecule
Molecular Formula:
C41H50N6O2
Molecular Weight:
658.89
AlogP:
9.58
PSA:
101.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
PF-03049423
2
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Phosphodiesterase 5A inhibitor
PF-03049423
×
Maximum Phase:
2
First Approval:
None
UNII:
9CZX3Z9945
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O4
Molecular Weight:
468.56
AlogP:
1.4
PSA:
105.84
HBD:
1.0
HBA:
#RotB:
10.0
Source:
VALOPICITABINE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
RNA-directed RNA polymerase inhibitor
VALOPICITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
I2T0B5G94M
Molecule Type:
Small molecule
Molecular Formula:
C15H24N4O6
Molecular Weight:
356.38
AlogP:
-1.64
PSA:
162.92
HBD:
4.0
HBA:
#RotB:
5.0
Source:
REMETINOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, T-Cell, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell
Unknown
REMETINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
37NT056AT4
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO6
Molecular Weight:
323.35
AlogP:
2.22
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VANOXERINE
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Atrial Flutter; Atrial Fibrillation
Unknown
VANOXERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
90X28IKH43
Molecule Type:
Small molecule
Molecular Formula:
C28H32F2N2O
Molecular Weight:
450.57
AlogP:
5.32
PSA:
15.71
HBD:
0.0
HBA:
#RotB:
10.0
Source:
LY2157299
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY2157299
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHOLESTEROL
2
Small molecule
Investigational
Unknown
Unknown
Asperger Syndrome; Autistic Disorder; Head and Neck Neoplasms; Porokeratosis; Smith-Lemli-Opitz Syndrome
Unknown
CHOLESTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
97C5T2UQ7J
Molecule Type:
Small molecule
Molecular Formula:
C27H46O
Molecular Weight:
386.66
AlogP:
7.39
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GW842166X
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Osteoarthritis, Knee; Pain
Cannabinoid CB2 receptor agonist
GW842166X
×
Maximum Phase:
2
First Approval:
None
UNII:
VL1I6P2DZ8
Molecule Type:
Small molecule
Molecular Formula:
C18H17Cl2F3N4O2
Molecular Weight:
449.26
AlogP:
4.7
PSA:
76.14
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MK-0873
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis; Arthritis, Rheumatoid; Lung Diseases; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
MK-0873
×
Maximum Phase:
2
First Approval:
None
UNII:
K4KAC9XCCO
Molecule Type:
Small molecule
Molecular Formula:
C25H18N4O3
Molecular Weight:
422.44
AlogP:
2.31
PSA:
90.93
HBD:
1.0
HBA:
#RotB:
3.0
Source:
HISTIDINE
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome; Hernias, Diaphragmatic, Congenital; Multiple Sclerosis
Unknown
HISTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4QD397987E
Molecule Type:
Small molecule
Molecular Formula:
C6H9N3O2
Molecular Weight:
155.16
AlogP:
-0.64
PSA:
92.0
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PEGSITACIANINE
2
Small molecule
Investigational
Unknown
Unknown
Diagnostic Imaging; Lymph Nodes; Neoplasms; Lung Neoplasms
Diagnostic
PEGSITACIANINE
×
Maximum Phase:
2
First Approval:
None
UNII:
49X2Q41T99
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEDATIOXETINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Alpha-1a adrenergic receptor antagonist
TEDATIOXETINE
×
Maximum Phase:
2
First Approval:
None
UNII:
5H681S8O3S
Molecule Type:
Small molecule
Molecular Formula:
C18H21NS
Molecular Weight:
283.44
AlogP:
4.61
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ATIPRIMOD
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Carcinoma, Neuroendocrine
Unknown
ATIPRIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
MG7D3QD743
Molecule Type:
Small molecule
Molecular Formula:
C22H44N2
Molecular Weight:
336.61
AlogP:
5.57
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
10.0
Source:
ORVEPITANT MALEATE
2
Small molecule
Investigational
Unknown
Unknown
Cough
Unknown
ORVEPITANT MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HAX0H28B6W
Molecule Type:
Small molecule
Molecular Formula:
C35H39F7N4O6
Molecular Weight:
744.71
AlogP:
6.8
PSA:
47.1
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TOLUENE
2
Small molecule
Investigational
Unknown
Unknown
Hot Flashes
Unknown
TOLUENE
×
Maximum Phase:
2
First Approval:
None
UNII:
3FPU23BG52
Molecule Type:
Small molecule
Molecular Formula:
C7H8
Molecular Weight:
92.14
AlogP:
2.0
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
RONACALERET
2
Small molecule
Investigational
Unknown
Unknown
Fractures, Bone; Osteoporosis
Calcium sensing receptor antagonist
RONACALERET
×
Maximum Phase:
2
First Approval:
None
UNII:
DIH95YP7J3
Molecule Type:
Small molecule
Molecular Formula:
C25H31F2NO4
Molecular Weight:
447.52
AlogP:
3.9
PSA:
78.79
HBD:
3.0
HBA:
#RotB:
11.0
Source:
VALEMETOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Hepatocellular; Lymphoma; Lymphoma, Non-Hodgkin
Unknown
VALEMETOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
60RD0234VE
Molecule Type:
Small molecule
Molecular Formula:
C26H34ClN3O4
Molecular Weight:
488.03
AlogP:
4.49
PSA:
83.66
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BVT.115959
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Adenosine A2a receptor agonist
BVT.115959
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O5
Molecular Weight:
297.27
AlogP:
-1.97
PSA:
148.77
HBD:
4.0
HBA:
#RotB:
3.0
Source:
IODOFILTIC ACID I 123
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Unknown
IODOFILTIC ACID I 123
×
Maximum Phase:
2
First Approval:
None
UNII:
0J7USQ749M
Molecule Type:
Small molecule
Molecular Formula:
C22H35IO2
Molecular Weight:
454.43
AlogP:
7.24
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
REMOGLIFLOZIN ETABONATE
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
REMOGLIFLOZIN ETABONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
TR0QT6QSUL
Molecule Type:
Small molecule
Molecular Formula:
C26H38N2O9
Molecular Weight:
522.6
AlogP:
2.51
PSA:
141.73
HBD:
3.0
HBA:
#RotB:
10.0
Source:
AFIMETORAN
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
Toll-like receptor 7 inhibitor
AFIMETORAN
×
Maximum Phase:
2
First Approval:
None
UNII:
LXP7MZL0VF
Molecule Type:
Small molecule
Molecular Formula:
C26H32N6O
Molecular Weight:
444.58
AlogP:
4.28
PSA:
92.31
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BI 44370 TA
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 44370 TA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAPANSUTRILE
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Melanoma; Myocardial Infarction; Diabetes Mellitus, Type 2; Schnitzler Syndrome; Severe Acute Respiratory Syndrome
NACHT, LRR and PYD domains-containing protein 3 inhibitor
DAPANSUTRILE
×
Maximum Phase:
2
First Approval:
None
UNII:
2Z03364G96
Molecule Type:
Small molecule
Molecular Formula:
C4H7NO2S
Molecular Weight:
133.17
AlogP:
-0.06
PSA:
57.93
HBD:
0.0
HBA:
#RotB:
2.0
Source:
AURICLOSENE MONOSODIUM MONOHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Conjunctivitis, Viral
Unknown
AURICLOSENE MONOSODIUM MONOHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4787JWS9HN
Molecule Type:
Small molecule
Molecular Formula:
C4H10Cl2NNaO4S
Molecular Weight:
262.09
AlogP:
1.26
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BERUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
BERUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
6QPN83HK2M
Molecule Type:
Small molecule
Molecular Formula:
C34H35NO11
Molecular Weight:
633.65
AlogP:
2.23
PSA:
195.07
HBD:
5.0
HBA:
#RotB:
8.0
Source:
OLEOYL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
OLEOYL
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H40NaO7P
Molecular Weight:
458.51
AlogP:
5.04
PSA:
113.29
HBD:
3.0
HBA:
#RotB:
20.0
Source:
PERFLENAPENT
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Echocardiography; Extravasation of Diagnostic and Therapeutic Materials
Ultrasound contrast agent
PERFLENAPENT
×
Maximum Phase:
2
First Approval:
None
UNII:
483AU1Y5CZ
Molecule Type:
Small molecule
Molecular Formula:
C5F12
Molecular Weight:
288.03
AlogP:
4.02
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TC-6987
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Diabetes Mellitus, Type 2
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
TC-6987
×
Maximum Phase:
2
First Approval:
None
UNII:
Q2U4R164OG
Molecule Type:
Small molecule
Molecular Formula:
C20H21F2N3O
Molecular Weight:
357.4
AlogP:
2.8
PSA:
45.23
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RV-521
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RV-521
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACLARUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid, Acute; Neoplasms
Unknown
ACLARUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
74KXF8I502
Molecule Type:
Small molecule
Molecular Formula:
C42H53NO15
Molecular Weight:
811.88
AlogP:
3.16
PSA:
217.05
HBD:
4.0
HBA:
#RotB:
9.0
Source:
INDOXIMOD
2
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Ependymoma; Glioblastoma; Gliosarcoma; Leukemia, Myeloid, Acute; Medulloblastoma; Neoplasms; Pancreatic Neoplasms; Paraganglioma; Breast Neoplasms; Melanoma; Prostatic Neoplasms
mTORC1 activator
INDOXIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
TX5CYN1KMZ
Molecule Type:
Small molecule
Molecular Formula:
C12H14N2O2
Molecular Weight:
218.26
AlogP:
1.13
PSA:
68.25
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
91
92
93
94
95
96
97
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA